Cargando…

Physical Exercise and Alzheimer’s Disease: Effects on Pathophysiological Molecular Pathways of the Disease

Alzheimer’s disease (AD), the most common form of neurodegenerative dementia in adults worldwide, is a multifactorial and heterogeneous disorder characterized by the interaction of genetic and epigenetic factors and the dysregulation of numerous intracellular signaling and cellular/molecular pathway...

Descripción completa

Detalles Bibliográficos
Autores principales:	López-Ortiz, Susana, Pinto-Fraga, Jose, Valenzuela, Pedro L., Martín-Hernández, Juan, Seisdedos, María M., García-López, Oscar, Toschi, Nicola, Di Giuliano, Francesca, Garaci, Francesco, Mercuri, Nicola Biagio, Nisticò, Robert, Emanuele, Enzo, Lista, Simone, Lucia, Alejandro, Santos-Lozano, Alejandro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7999827/ https://www.ncbi.nlm.nih.gov/pubmed/33809300 http://dx.doi.org/10.3390/ijms22062897

Ejemplares similares

A Path Toward Precision Medicine for Neuroinflammatory Mechanisms in Alzheimer's Disease
por: Hampel, Harald, et al.
Publicado: (2020)

Physical Exercise and the Hallmarks of Breast Cancer: A Narrative Review
por: García-Chico, Celia, et al.
Publicado: (2023)

Biomarker-guided classification scheme of neurodegenerative diseases
por: Baldacci, Filippo, et al.
Publicado: (2016)

Pathophysiological Features of Nigral Dopaminergic Neurons in Animal Models of Parkinson’s Disease
por: Guatteo, Ezia, et al.
Publicado: (2022)

Validation and Determination of Physical Activity Intensity GT3X+ Cut-Points in Children and Adolescents with Physical Disabilities: Preliminary Results in a Cerebral Palsy Population
por: Matey-Rodríguez, Carmen, et al.
Publicado: (2023)

Coronavirus Lockdown: Forced Inactivity for the Oldest Old?
por: Valenzuela, Pedro L., et al.
Publicado: (2020)

Profile of gantenerumab and its potential in the treatment of Alzheimer’s disease
por: Novakovic, Dijana, et al.
Publicado: (2013)

The Importance of Diagnosing and the Clinical Potential of Treating Obstructive Sleep Apnea to Delay Mild Cognitive Impairment and Alzheimer’s Disease: A Special Focus on Cognitive Performance
por: Fernandes, Mariana, et al.
Publicado: (2021)

Lipidomics of Bioactive Lipids in Alzheimer’s and Parkinson’s Diseases: Where Are We?
por: Chiurchiù, Valerio, et al.
Publicado: (2022)

Successful aging: insights from proteome analyses of healthy centenarians
por: Santos-Lozano, Alejandro, et al.
Publicado: (2020)

Sleep dysregulation, memory impairment, and CSF biomarkers during different levels of neurocognitive functioning in Alzheimer’s disease course
por: Liguori, Claudio, et al.
Publicado: (2020)

Correction to: Sleep dysregulation, memory impairment, and CSF biomarkers during different levels of neurocognitive functioning in Alzheimer’s disease course
por: Liguori, Claudio, et al.
Publicado: (2020)

MRI and Clinical Biomarkers Overlap between Glaucoma and Alzheimer’s Disease
por: Martucci, Alessio, et al.
Publicado: (2023)

Apolipoproteins and Alzheimer's pathophysiology
por: Koch, Manja, et al.
Publicado: (2018)

TRPA1 Expression and Pathophysiology in Immune Cells
por: Naert, Robbe, et al.
Publicado: (2021)

Role of Calcium Modulation in the Pathophysiology and Treatment of Alzheimer’s Disease
por: Baracaldo-Santamaría, Daniela, et al.
Publicado: (2023)

Inflammation and the pathophysiology of Alzheimer's disease
por: Greer, M. Murphy Jr.
Publicado: (2000)

mGluR1-Dependent Long Term Depression in Rodent Midbrain Dopamine Neurons Is Regulated by Neuregulin 1/ErbB Signaling
por: Ledonne, Ada, et al.
Publicado: (2018)

Could the New Anti-CGRP Monoclonal Antibodies Be Effective in Migraine Aura? Case Reports and Literature Review
por: Albanese, Maria, et al.
Publicado: (2022)

Spectral Domain Optical Coherence Tomography Assessment of Macular and Optic Nerve Alterations in Patients with Glaucoma and Correlation with Visual Field Index
por: Martucci, Alessio, et al.
Publicado: (2018)

Linking Migraine to Gut Dysbiosis and Chronic Non-Communicable Diseases
por: Di Lauro, Manuela, et al.
Publicado: (2023)

Imaging Alzheimer's disease pathophysiology with PET
por: Schilling, Lucas Porcello, et al.
Publicado: (2016)

α-synuclein in the pathophysiology of Alzheimer’s disease
por: Twohig, Daniel, et al.
Publicado: (2019)

Local Sleep and Alzheimer’s Disease Pathophysiology
por: Mander, Bryce A.
Publicado: (2020)

Alzheimer’s Disease: An Update and Insights Into Pathophysiology
por: Abubakar, Murtala Bello, et al.
Publicado: (2022)

Hypothesis on ontogenesis and pathophysiology of Alzheimer’s disease
por: Schwab, Eduarda Dal Pisol, et al.
Publicado: (2022)

Role of Citrate in Pathophysiology and Medical Management of Bone Diseases
por: Granchi, Donatella, et al.
Publicado: (2019)

The immune response as a therapeutic target in non-alcoholic fatty liver disease
por: Ortiz-López, Nicolás, et al.
Publicado: (2022)

Functional Correlates of Microglial and Astrocytic Activity in Symptomatic Sporadic Alzheimer’s Disease: A CSF/(18)F-FDG-PET Study
por: Bonomi, Chiara Giuseppina, et al.
Publicado: (2023)

Sleep Dysregulation Is Associated with (18)F-FDG PET and Cerebrospinal Fluid Biomarkers in Alzheimer’s Disease
por: Fernandes, Mariana, et al.
Publicado: (2023)

Alzheimer’s Disease and SARS-CoV-2: Pathophysiological Analysis and Social Context
por: Ortiz, Genaro Gabriel, et al.
Publicado: (2022)

Emerging Roles of Protease-Activated Receptors (PARs) in the Modulation of Synaptic Transmission and Plasticity
por: Price, Rachel, et al.
Publicado: (2021)

Disease trajectories in elders with suspected non-Alzheimer’s pathophysiology and its comparison with Alzheimer’s disease pathophysiology: a longitudinal study
por: Li, Jie-Qiong, et al.
Publicado: (2023)

Different associations between amyloid-βeta 42, amyloid-βeta 40, and amyloid-βeta 42/40 with soluble phosphorylated-tau and disease burden in Alzheimer’s disease: a cerebrospinal fluid and fluorodeoxyglucose-positron emission tomography study
por: Motta, Caterina, et al.
Publicado: (2023)

Effects of melatonin prolonged-release on both sleep and motor symptoms in Parkinson’s disease: a preliminary evidence
por: Liguori, Claudio, et al.
Publicado: (2022)

Alzheimer’s disease and type 2 diabetes mellitus: Pathophysiologic and pharmacotherapeutics links
por: Rojas, Milagros, et al.
Publicado: (2021)

Biological Mechanism-based Neurology and Psychiatry: A BACE1/2 and Downstream Pathway Model
por: Hampel, Harald, et al.
Publicado: (2023)

Primary Open Angle Glaucoma Is Associated With Functional Brain Network Reorganization
por: Minosse, Silvia, et al.
Publicado: (2019)

Pathophysiological insights in sickle cell disease
por: Odièvre, Marie-Hélène, et al.
Publicado: (2011)

The pathophysiology of thrombocytopenia in chronic liver disease
por: Mitchell, Oscar, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_63kdb21qs4hnctfd2th7pdamou